BridgeBio Oncology Therapeutics
IPOBridgeBio Oncology Therapeutics (BBOT) | Best-in-RAS
BridgeBio Oncology Therapeutics was founded in 2024, is headquartered in South San Francisco, United States, lists 51–200 employees, and has $200.0M in recorded funding across 1 round.
- Headquarters
- South San Francisco
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- bbotx.com
- Total Funding
- $200.0M
- Last Round
- $200.0M Series BMay 2024
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.
About
BridgeBio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio Pharma, BBOT completed a $200M private financing in May 2024 with leading oncology investors. The company is advancing three programs — BBO-8520, BBO-10203, and BBO-11818 — targeting KRAS and PI3Kα pathway cancers.
Summary
BridgeBio Oncology Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2024. It lists 51–200 employees. It has raised $200.0M in total across 1 round, most recently a $200.0M Series B round in May 2024. Investors include Cormorant Asset Management, Omega Funds and Deerfield Management.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Aug 2025
Sign up to see all 2 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bridgebio-oncology-therapeutics"><img src="https://indexed.vc/api/badge/company/bridgebio-oncology-therapeutics" alt="BridgeBio Oncology Therapeutics on Indexed.vc" width="260" height="76" /></a>